Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Interaction Between Mesenchymal Stromal Cell-Derived Extracellular Vesicles and Immune Cells by Distinct Protein Content Publisher Pubmed



Mardpour S1, 2 ; Hamidieh AA3 ; Taleahmad S2 ; Sharifzad F4 ; Taghikhani A5 ; Baharvand H2, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Tissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  3. 3. Pediatric Stem Cell Transplant Department, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Applied Cell Sciences, Kashan University of Medical Sciences, Kashan, Iran
  5. 5. Department of Immunology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran
  6. 6. Department of Developmental Biology, University of Science and Culture, Tehran, Iran

Source: Journal of Cellular Physiology Published:2019


Abstract

Mesenchymal stromal cells (MSCs) can effectively contribute to tissue regeneration inside the inflammatory microenvironment mostly through modulating immune responses. MSC-derived extracellular vesicles (MSC-EVs) display immunoregulatory functions similar to parent cells. Interactions between MSC-EVs and immune cells make them an ideal therapeutic candidate for infectious, inflammatory, and autoimmune diseases. These properties of MSC-EVs have encouraged researchers to perform extensive studies on multiple factors that mediate MSC-EVs immunomodulatory effects. Investigation of proteins involved in the complex interplay of MSC-EVs and immune cells may help us to better understand their functions. Here, we performed a comprehensive proteomic analysis of MSC-EVs that was previously reported by ExoCarta database. A total of 938 proteins were identified as MSC-EV proteome using quantitative proteomics techniques. Kyoto Encyclopedia of Genes and Genomes analysis demonstrates that ECM–receptor interaction, focal adhesion, and disease-specific pathways are enriched in MSC-EVs. By detail analysis of proteins presence in immune system process, we found that expression of some cytokines, chemokines, and chemokine receptors such as IL10, HGF, LIF, CCL2, VEGFC, and CCL20, which leads to migration of MSC-EVs to injured sites, suppression of inflammation and promotion of regeneration in inflammatory and autoimmune diseases. Also, some chemoattractant proteins such as CXCL2, CXCL8, CXCL16, DEFA1, HERC5, and IFITM2 were found in MSC-EV proteome. They may actively recruit immune cells to the proximity of MSC or MSC-EVs, may result in boosting immune response under specific circumstances, and may have protective role in infectious diseases. In this review, we summarize available information about immunomodulation of MSC-EVs with particular emphasis on their proteomics analysis. © 2018 Wiley Periodicals, Inc.
Related Docs
View other Related Docs
1. The Extracellular Vesicles-Derived From Mesenchymal Stromal Cells: A New Therapeutic Option in Regenerative Medicine, Journal of Cellular Biochemistry (2018)
2. Mesenchymal Stem Cells: Rising Concerns Over Their Application in Treatment of Type One Diabetes Mellitus, Journal of Diabetes Research (2015)
3. Exosomes As a Novel Cell-Free Therapeutic Approach in Gastrointestinal Diseases, Journal of Cellular Physiology (2019)
4. Extracellular Vesicles Derived From Human Embryonic Stem Cell-Mscs Ameliorate Cirrhosis in Thioacetamide-Induced Chronic Liver Injury, Journal of Cellular Physiology (2018)
5. Utilization of Mesenchymal Stem Cells in Kidney Transplantation: From Bench to Bedside, Iranian Journal of Kidney Diseases (2019)
6. Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Ace Card to Address Autoimmune Diseases, International Journal of Stem Cells (2020)
7. Immunomodulatory Characteristics of Mesenchymal Stem Cells and Their Role in the Treatment of Multiple Sclerosis, Cellular Immunology (2015)
8. Umbilical Cord Mesenchymal Stem Cells As Well As Their Released Exosomes Suppress Proliferation of Activated Pbmcs in Multiple Sclerosis, Scandinavian Journal of Immunology (2021)
Experts (# of related papers)
View all Related Experts
Somayeh Ebrahimi Barough (5)
Bagher Larijani (5)
Other Related Docs
9. Texosome-Based Drug Delivery System for Cancer Therapy: From Past to Present, Cancer Biology and Medicine (2015)
10. The Critical Role of Mesenchymal Stromal/Stem Cell Therapy in Covid-19 Patients: An Updated Review, Cell Biochemistry and Function (2021)
11. The Therapeutic Potential of Mesenchymal Stem Cell–Derived Exosomes in Treatment of Neurodegenerative Diseases, Molecular Neurobiology (2019)
12. Mesenchymal Stem Cells Induce Expansion of Regulatory T Cells in Abortion-Prone Mice, Reproduction (2021)
13. Extracellular Vesicles in Bone and Periodontal Regeneration: Current and Potential Therapeutic Applications, Cell and Bioscience (2021)
14. The Emerging Role of Exosomal Mirnas As a Diagnostic and Therapeutic Biomarker in Mycobacterium Tuberculosis Infection, Molecular Medicine (2021)
15. The Mechanisms of Cellular Crosstalk Between Mesenchymal Stem Cells and Natural Killer Cells: Therapeutic Implications, Journal of Cellular Physiology (2021)
16. Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy, Frontiers in Immunology (2020)
17. Mechanisms and Potentials of Stem Cells in the Treatment of Multiple Sclerosis: The Unpaved Path, Multiple Sclerosis: A Mechanistic View (2016)
18. Manipulated Mesenchymal Stem Cells Applications in Neurodegenerative Diseases, International Journal of Stem Cells (2020)
19. Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents, Current Medicinal Chemistry (2016)
20. Mesenchymal Stromal Cells (Mscs) for Neurodegenerative Disease: A Promising Frontier, European Journal of Cell Biology (2020)
21. Immunomodulatory Potential of Human Mesenchymal Stem Cells and Their Exosomes on Multiple Sclerosis, Advanced Pharmaceutical Bulletin (2022)
22. Minimal Information for Studies of Extracellular Vesicles (Misev2023): From Basic to Advanced Approaches, Journal of Extracellular Vesicles (2024)
23. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
24. The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis, Advances in Experimental Medicine and Biology (2021)
25. Cancer-Associated Mesenchymal Stem/Stromal Cells: Role in Progression and Potential Targets for Therapeutic Approaches, Frontiers in Immunology (2023)
26. Extracellular Micro/Nanovesicles Rescue Kidney From Ischemia-Reperfusion Injury, Journal of Cellular Physiology (2019)
27. Exosomal Micrornas Derived From Mesenchymal Stem Cells: Cell-To-Cell Messages, Cell Communication and Signaling (2020)
28. Mesenchymal Stromal Cells; a New Horizon in Regenerative Medicine, Journal of Cellular Physiology (2020)
29. Genetically Engineered Mesenchymal Stromal Cells As a New Trend for Treatment of Severe Acute Graft-Versus-Host Disease, Clinical and Experimental Immunology (2022)
30. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to Be Aware Of, Current Pharmaceutical Biotechnology (2021)
31. Overview of Mesenchymal Stem Cells, Stem Cells in Urology (2020)
32. Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy, OncoImmunology (2020)
33. Induced Pluripotent Stem Cell-Derived Extracellular Vesicles: A Novel Approach for Cell-Free Regenerative Medicine, Journal of Cellular Physiology (2019)
34. Extracellular Vesicles As a Neprilysin Delivery System Memory Improvement in Alzheimer’S Disease, Iranian Journal of Pharmaceutical Research (2020)
35. Endometrial and Menstrual Blood Mesenchymal Stem/Stromal Cells: Biological Properties and Clinical Application, Frontiers in Cell and Developmental Biology (2020)
36. Novel Cell-Based Therapies in Inflammatory Bowel Diseases: The Established Concept, Promising Results, Human Cell (2021)
37. Menstrual Blood-Derived Stromal Stem Cells Augment Cd4+ T Cells Proliferation, Avicenna Journal of Medical Biotechnology (2018)
38. Hypoxia Preconditioned Mesenchymal Stem Cell-Derived Exosomes Induce Ex Vivo Expansion of Umbilical Cord Blood Hematopoietic Stem Cells Cd133+ by Stimulation of Notch Signaling Pathway, Biotechnology Progress (2022)
39. Study the Effects of Mesenchymal Stem Cell Conditioned Medium Injection in Mouse Model of Acute Colitis, International Immunopharmacology (2018)
40. Application of Extracellular Vesicles in the Treatment of Inflammatory Bowel Disease, Koomesh (2020)
41. Mesenchymal Stem Cells-Derived Exosomes for Wound Regeneration, Advances in Experimental Medicine and Biology (2018)
42. Mesenchymal Stem Cell Transplantation in Systemic Lupus Erythematous, a Mesenchymal Stem Cell Disorder, Lupus (2018)
43. Isolation and Characterization of Mesenchymal Stem Cells-Derived Exosomes by Method of Ultracentrifuge and Polyethylene Glycol, Journal of Isfahan Medical School (2020)
44. Mesenchymal Stem/Stroma Cell (Msc)-Derived Nanoscale Exosomes Inhibit T Cell Proliferation by Negative Regulation of Pi3k/Akt and Mapk/Erk Pathway, Nanomedicine Research Journal (2022)
45. Culture Density of Menstrual Blood-Derived Stromal/Stem Cells Determines the Quality of T Cell Responses: An Experimental Study, International Journal of Reproductive BioMedicine (2021)
46. Evaluation of Immunomodulatory Effects of Co-Culture or Supernatant of Dexamethasone or Ifn-Γ-Treated Adipose-Derived Mesenchymal Stem Cells on Spleen Mononuclear Cells, European Cytokine Network (2022)
47. Anti-Inflammatory Effects of Plasma Circulating Exosomes Obtained From Normal-Weight and Obese Subjects on Hepatocytes, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
48. Immunomodulatory Activity of Human Bone Marrow and Adipose-Derived Mesenchymal Stem Cells Prolongs Allogenic Skin Graft Survival in Nonhuman Primates, Cell Journal (2021)
49. Administration of Autologous Mesenchymal Stem Cell Transplantation for Treatment of Type 1 Diabetes Mellitus, Iranian Journal of Public Health (2015)
50. Adipose Derived Mesenchymal Stem Cell Exosomes Loaded With Mir-10A Promote the Differentiation of Th17 and Treg From Naive Cd4+ T Cell, Life Sciences (2020)